As of Jun 22
| +0.01 / +1.92%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +135.18% increase from the last price of 0.53.
The current consensus among 1 polled investment analysts is to Buy stock in ARCA Biopharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.